[Federal Register Volume 63, Number 52 (Wednesday, March 18, 1998)]
[Notices]
[Pages 13264-13265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-6956]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institutes of Arthritis and Musculoskeletal and Skin Diseases 
Special Emphasis Panel (SEP) meeting.

    Name of SEP: Clinical Trial (TELECONFERENCE).
    Date: April 4, 1998.
    Time: 4:00 p.m. (ET)--adjournment.
    Place: National Institutes of Health, Natcher Building, Room 
5AS25U, Bethesda, Maryland 20852.
    Contact Person: Tommy Broadwater, Ph.D., Chief, Grants Review 
Branch, Natcher Building, Room 5AS25U, Bethesda, Maryland 20892, 
Telephone: 301-594-4952.
    Purpose/Agenda: To evaluate and review a grant application.
    This meeting will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The 
discussion of this application could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with this 
application, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. [93.846, 
Project Grants in Arthritis, Musculoskeletal and Skin Diseases 
Research], National Institutes of Health, HHS)


[[Page 13265]]


    Dated: March 11, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-6956 Filed 3-17-98; 8:45 am]
BILLING CODE 4140-01-M